HomeInsightsStock Comparison

Mankind Pharma Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Mankind Pharma Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 05, 2025

Key Highlights

  • The Latest Trading Price of Mankind Pharma Ltd is ₹ 2606 as of 05 Aug 10:54.
  • The P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 50.2 on March 2025 . This represents a CAGR of 2.16% over 2 yearsThe P/E Ratio of SMS Pharmaceuticals Ltd changed from 7.1 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The Market Cap of Mankind Pharma Ltd changed from ₹ 92029 crore on March 2024 to ₹ 99973 crore on March 2025 . This represents a CAGR of 4.23% over 2 yearsThe Market Cap of SMS Pharmaceuticals Ltd changed from ₹ 225.6 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Mankind Pharma Ltd for the Jun '25 is ₹ 3653 crore as compare to the Mar '25 revenue of ₹ 3333 crore. This represent the growth of 9.61% The revenue of SMS Pharmaceuticals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 249.62 crore. This represent the decline of -100%.
  • The ebitda of Mankind Pharma Ltd for the Jun '25 is ₹ 929.82 crore as compare to the Mar '25 ebitda of ₹ 932.5 crore. This represent the decline of -0.29% The ebitda of SMS Pharmaceuticals Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 42.23 crore. This represent the decline of -100%.
  • The net profit of Mankind Pharma Ltd changed from ₹ 494.19 crore to ₹ 444.62 crore over 9 quarters. This represents a CAGR of -4.59% The net profit of SMS Pharmaceuticals Ltd changed from ₹ 8.81 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Mankind Pharma Ltd changed from 31.56 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of SMS Pharmaceuticals Ltd changed from 6.48 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Mankind Pharma Ltd

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

About SMS Pharmaceuticals Ltd

  • SMS Pharmaceuticals Limited was incorporated in December, 1987.
  • The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
  • Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24. During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs. 10/- each in M/s.
  • VKT Pharma Private Limited.

Mankind Pharma Ltd News Hub

News

Board of Mankind Pharma recommends Interim Dividend

Mankind Pharma announced that the Board of Directors of the Company at its meeting held on...

Read more

31 Jul 2025 17:41

News

Mankind Pharma to convene board meeting

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 31 July 202...

Read more

15 Jul 2025 10:48

News

Mankind Pharma Ltd spurts 2.92%, gains for five straight sessions

Mankind Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 265...

Read more

14 Jul 2025 13:00

News

Mankind Pharma AGM scheduled

Mankind Pharma announced that the 34th Annual General Meeting(AGM) of the company will be ...

Read more

04 Jul 2025 16:31

News

Mankind Pharma allots 57,709 equity shares under ESOP

Mankind Pharma has allotted 57,709 equity shares of face value of Re. 1/- each of the Comp...

Read more

10 Jun 2025 13:26

News

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs ...

Read more

23 May 2025 13:35

SMS Pharmaceuticals Ltd News Hub

News

SMS Pharmaceuticals to convene board meeting

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 Augu...

Read more

04 Aug 2025 11:55

News

SMS Pharma's Hyderabad facility clears USFDA inspection with zero observations

The inspection was conducted from 23rd June 2025 to 25th June 2025, concluded with zero Fo...

Read more

26 Jun 2025 08:27

News

Board of SMS Pharmaceuticals recommends final dividend

SMS Pharmaceuticals announced that the Board of Directors of the Company at its meeting he...

Read more

31 May 2025 14:45

News

SMS Pharmaceuticals to announce Quarterly Result

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May...

Read more

24 May 2025 18:31

News

SMS Pharmaceuticals' Unit VII receives WHO Geneva prequalification

SMS Pharmaceuticals announced that Unit VII manufacturing facility in Visakhapatnam, Andhr...

Read more

02 May 2025 12:36

News

SMS Pharma gains after Hyderabad facility completes USFDA inspection

According to an exchange filing, the inspection was conducted from 17 March to 21 March 20...

Read more

24 Mar 2025 09:59

SWOT Analysis Of Mankind Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of SMS Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Mankind Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for SMS Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Mankind Pharma Ltd and SMS Pharmaceuticals Ltd

Which company has a larger market capitalization, Mankind Pharma Ltd or SMS Pharmaceuticals Ltd?

Market cap of Mankind Pharma Ltd is 108,481 Cr while Market cap of SMS Pharmaceuticals Ltd is 2,018 Cr

What are the key factors driving the stock performance of Mankind Pharma Ltd and SMS Pharmaceuticals Ltd?

The stock performance of Mankind Pharma Ltd and SMS Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mankind Pharma Ltd and SMS Pharmaceuticals Ltd?

As of August 5, 2025, the Mankind Pharma Ltd stock price is INR ₹2628.4. On the other hand, SMS Pharmaceuticals Ltd stock price is INR ₹227.65.

How do dividend payouts of Mankind Pharma Ltd and SMS Pharmaceuticals Ltd compare?

To compare the dividend payouts of Mankind Pharma Ltd and SMS Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions